| Product Name | MF | CAS | Details |
|---|
| (4S)-Hexahydro-1-methyl-2,6-dioxo-4-pyrimidinecarbonyl-L-histidyl-L-proline | C17H22N6O6 | 103300-77-2 | Details |
| Dibenzo[def,p]chrysene | C24H14 | 191-30-0 | Details |
| 3-Methoxybenzyl bromide | C8H9BrO | 874-98-6 | Details |
| H-YPHTHLVQQANPR^-OH | Details |
| c20 Ceramide (d17:1/20:0) | C37H73NO3 | 474944-00-8 | Details |
| Nε-Methyl-L-lysine hydrochloride | C7H17ClN2O2 | 7622-29-9 | Details |
| Cerulenin | C12H17NO3 | 17397-89-6 | Details |
| COOH-PEG3-NHS | C14H21NO9 | 1835759-79-9 | Details |
| 3-[(Pyrrolidin-3-yl)amino]benzonitrile hydrochloride | C11H14ClN3 | 1955531-78-8 | Details |
| 5-Iodo-4-methylpyrimidin-2-amine | C5H6IN3 | 22294-56-0 | Details |
| 1-Fluorononane | C9H19F | 463-18-3 | Details |
| Danshenol B | C22H26O4 | 189308-09-6 | Details |
| 5-Amino-1-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione | C5H7N3O2 | 23899-79-8 | Details |
| Presenilin 1 Blocking Peptide | Details |
| Eupahualin C | C20H24O6 | 108525-39-9 | Details |
| 3,5-Dimethoxyphenylacetic acid | C10H12O4 | 4670-10-4 | Details |
| beta-Cryptoxanthin - 1% | C40H56O | 472-70-8 | Details |
| 3-(1,1-Difluoroethyl)benzonitrile | C9H7F2N | 55805-06-6 | Details |
| ACAC antibody | Details |
| Rapastinel trifluoroacetate | C20H32F3N5O8 | 1435786-04-1 | Details |
| 1,3,5-Triazine-2,4,6-triyltriiminotrimethanol | C6H12N6O3 | 1017-56-7 | Details |
| Nitrovin | C14H12N6O6 | 804-36-4 | Details |
| (25RS)-Ruscogenin | C27H42O4 | 874485-32-2 | Details |
| Ethyl 4-iodobenzoate | C9H9IO2 | 51934-41-9 | Details |
| Benzyl 4,6-O-benzylidene-2-deoxy-2-phthalimido-b-D-glucopyranoside | C28H25NO7 | 80035-33-2 | Details |
| MRPS25 antibody | Details |
| Tb-alpha Heavy | Details |
| (-)-Menthylchloride | C10H19Cl | 16052-42-9 | Details |
| 2,4-Diaminopyrimidine-5-carbonitrile | C5H5N5 | 16462-27-4 | Details |
| 3'-O-Acetyl-2'-deoxycytidine | C11H15N3O5 | 72560-69-1 | Details |
| 2-(4-Cyclopropoxyphenyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane | C15H21BO3 | 1398503-71-3 | Details |
| Cardiolipin | C81H140Na2O17P2 | 383907-10-6 | Details |
| KCNN1 Blocking Peptide | Details |
| 2-[2-(Propan-2-yl)pyrimidin-5-yl]ethan-1-amine | C9H15N3 | 944905-69-5 | Details |
| 13,14-Dihydroxydocosahexaenoic acid | C22H32O4 | 1639809-46-3 | Details |
| (Val34)-Amyloid b-Protein (1-40) trifluoroacetate salt | 1678415-83-2 | Details |
| H-KAPDNRETL-OH | Details |
| N-(2-Methylphenyl)-1,3-benzothiazol-2-amine | C14H12N2S | 25717-12-8 | Details |
| Propan-2-yl 4-(chloromethyl)benzoate | C11H13ClO2 | 87234-10-4 | Details |
| ETF1 antibody | Details |
| 5-(Benzyloxy)-7-methyl-1H-indole | C16H15NO | 4792-65-8 | Details |
| Hyaluronic acid potassium salt - from Cockscomb | (C14H20KNO11)n | 31799-91-4 | Details |
| 8,9-Dihydroxy-1,5,6,10b-tetrahydropyrrolo[2,1-a]isoquinolin-3(2H)-one | C12H13NO3 | 1021950-79-7 | Details |
| 2-(4-Aminothian-4-yl)ethan-1-ol hydrochloride | 2241138-41-8 | Details |
| TXNRD3 antibody | Details |
| 2-Amino-3-hydroxy-3-(4-methoxyphenyl)propanoic acid | C10H13NO4 | 50897-30-8 | Details |
| 4-(2,3-Dimethylphenyl)-1,2,3,6-tetrahydropyridine | C13H17N | 194669-34-6 | Details |
| 4-Phenyl-3-buten-2-one | C10H10O | 122-57-6 | Details |
| 2-Hydroxy-3-(1-methyl-1H-imidazol-4-yl)propanoic acid hydrochloride | C7H11ClN2O3 | 2228364-65-4 | Details |
| 5-Bromo-4-chloro-2-methylbenzene-1-sulfonyl chloride | C7H5BrCl2O2S | 1416349-30-8 | Details |
| EMT antibody | Details |
| [2S- (2a, 3a, 4b, 5b, 6a) ]-2- (Hydroxymethyl) - 6- methyl- 3, 4, 5- piperidinetriol | Details |
| 3-Amino-1-(propan-2-yl)-1H-pyrazole-5-carboxylic acid | C7H11N3O2 | 1006451-79-1 | Details |
| 1-Chloro-8-methylisoquinoline | C10H8ClN | 174873-81-5 | Details |
| 1-Ethynylcycloheptan-1-ol | C9H14O | 2809-78-1 | Details |
| 7-Fluoro-1H-indazole-4-carbaldehyde | C8H5FN2O | 1186334-92-8 | Details |
| KIAA0317 antibody | Details |
| Quinazolin-6-ol | C8H6N2O | 7556-93-6 | Details |
| 1-(2-Amino-2-phenylethyl)pyrrolidin-2-one | C12H16N2O | 43003-24-3 | Details |
| Goat anti Human IgM (mu chain) (rhodamine) | Details |
| (5-Methoxypyridin-3-yl)methanamine dihydrochloride | C7H11ClN2O | 1955523-54-2 | Details |
| Prolactin-Releasing Peptide (12-31) (human) | C104H158N32O26 | 235433-36-0 | Details |
| {2-Benzyl-2-azabicyclo[2.2.1]heptan-3-yl}methanol | C14H19NO | 2168581-88-0 | Details |
| N-(4-Amino-2-chlorophenyl)methanesulfonamide | C7H9ClN2O2S | 18735-42-7 | Details |
| P,P'-Diphenylethylenediphosphinic acid | C14H16O4P2 | 1089-77-6 | Details |
| 3-[(4-Aminophenyl)formamido]propanamide | C10H13N3O2 | 1114822-89-7 | Details |
| 4-Bromo-8-methoxyquinoline | C10H8BrNO | 103028-31-5 | Details |
| Hydroxymethyl resin (100-200 mesh) | C8H10O | 66072-40-0 | Details |
| ethyl 2-cyano-3-(4-nitrophenyl)prop-2-enoate | C12H10N2O4 | 2017-89-2 | Details |
| [Glu1]-Fibrinopeptide B | C66H95N19O26 | 103213-49-6 | Details |
| H-WELGEGAFGK-OH | Details |
| (1-Methanesulfinylpropan-2-yl)(methyl)amine | C5H13NOS | 1379096-71-5 | Details |
| Fmoc-beta-Ala-4-amino-D-Phe(Boc)-OH | Details |
| 2-Chloro-4-phenyl-1,3-thiazole-5-sulfonyl chloride | C9H5Cl2NO2S2 | 2138159-10-9 | Details |
| (2S)-2-(2-Fluorobenzenesulfonamido)-3-phenylpropanoic acid | C15H14FNO4S | 1212370-86-9 | Details |
| 1,4-Dithian-2-ylmethanamine | C5H11NS2 | 15980-17-3 | Details |
| 1-(3-Cyclopropylphenyl)ethan-1-amine | C11H15N | 1247836-01-6 | Details |
| tert-Butyl N-(4-methoxybutyl)carbamate | C10H21NO3 | 1803589-07-2 | Details |
| 2-[(3-Ethynylphenyl)amino]-1-(morpholin-4-yl)ethan-1-one | C14H16N2O2 | 1021083-28-2 | Details |
| 3-Amino-2-(4,4-difluorocyclohexyl)-1,1,1-trifluoropropan-2-ol hydrochloride | 2375270-96-3 | Details |
| 2-Bromo-4-[(2-chlorobenzyl)oxy]-5-methoxybenzaldehyde | C15H12BrClO3 | 340216-55-9 | Details |
| 3'-Sialyl Lewis X-BSA | Details |
| D-Glucose 3-sulfate sodium salt | C6H13NaO9S | 89830-83-1 | Details |
| Anti Humanin Serum | Details |
| Methyl 4-azaspiro[2.5]octane-7-carboxylate hydrochloride | C9H16ClNO2 | 2253630-26-9 | Details |
| Adiponectin antibody (FITC) | Details |
| tert-Butyl 2-(piperidin-3-yl)pyrrolidine-1-carboxylate | C14H26N2O2 | 929973-31-9 | Details |
| 2-{5-Methoxy-1H-pyrrolo[3,2-b]pyridin-3-yl}ethan-1-amine | C10H13N3O | 1171071-94-5 | Details |
| (R)-(+)-Methylsuccinic acid | C5H8O4 | 3641-51-8 | Details |
| 4-Chloro-2-methyl-3-(propan-2-yl)quinoline | C13H14ClN | 357951-57-6 | Details |
| 1-{1-Benzyl-2-azabicyclo[2.1.1]hexan-2-yl}ethan-1-one | 2248324-87-8 | Details |
| Perfluorooctanoyl fluoride | C8F16O | 335-66-0 | Details |
| MAP Kinase Substrate | C101H172N30O32 | 137348-21-1 | Details |
| PSMD1 Blocking Peptide | Details |
| Methyl 1-azabicyclo[2.2.2]octane-4-carboxylate | C9H15NO2 | 51069-26-2 | Details |
| 2-(2,6-Dimethylpiperazin-1-yl)ethan-1-amine | C8H19N3 | 468745-67-7 | Details |
| ZNF778 Blocking Peptide | Details |
| 1-(Methoxycarbonyl)pyrrolidine-2-carboxylic acid | C7H11NO4 | 134250-76-3 | Details |
| 6-Methyl-N-(pyrrolidin-3-ylmethyl)pyridin-2-amine | C11H17N3 | 1258640-10-6 | Details |
| H-VIILGDSGVGK-OH | Details |
| Product Total： Product Page： | ||||
| 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 117 118 119 120 121 122 123 124 125 126 127 128 129 | ||||